Identification of genetic factors that predispose to either immune checkpoint inhibitor or conventional chemotherapy toxicity

Medicine & Life Sciences

1. Circulating Neoplastic Cells 100%
2. Squamous Cell Carcinoma of Head and Neck 89%
3. Genetic Variation 77%
4. Proteomics 74%
5. Autoimmune Diseases 27%
6. Epithelial-Mesenchymal Transition 27%
7. Neoplasms 19%
8. Immune System Diseases 17%
9. Genome-Wide Association Study 16%
10. Immunity 13%
11. Patient Care 12%
12. Genome 10%
13. T-Lymphocytes 9%
14. Therapeutics 9%
15. Single-Cell Analysis 7%
16. Microfluidics 6%
17. Cell Lineage 5%
18. Tumor Biomarkers 5%